Form 8-K - Current report:
SEC Accession No. 0001193125-19-239969
Filing Date
2019-09-06
Accepted
2019-09-06 16:08:32
Documents
2
Period of Report
2019-09-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d692580d8k.htm 8-K 17400
2 EX-99.1 d692580dex991.htm EX-99.1 7501
  Complete submission text file 0001193125-19-239969.txt   26199
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

EIN.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38871 | Film No.: 191079748
SIC: 2834 Pharmaceutical Preparations